· Trials · Research Desk
A machine-learning platform maps T-cell receptor specificity across large peptide libraries, opening a path to disease-associated antigen discovery and next-generation peptide therapeutics.
This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.
For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.